Carlos Henrique Ferreira Cruz

Thoracic surgeon. An affair with intensive care medicine and US. Doctor fascinated by surgical education, for better people care.

[Medicina Interna HCSBA @MHcsba]

New England Journal fo Medicine (NEJM) 2026: Nódulos pulmonares
DOI: 10.1056/NEJMcp2515063
#MedEd #MedTwitter #MedX
https://t.co/mPnd2VIWaZ

[Critical Care Reviews @CritCareReviews]

Evidence-based, cost-effective management of empyema and chylothorax: An algorithm of the Journal of Trauma and Acute Care Surgery Emergency General Surgery Algorithms work group

CCR Journal Watch
https://t.co/Sp06oA6IDG

[SAB @SABronchoscopy]

#SAB proudly endorses this hands-on IP course! Oct 23-24, 2026 | Jacksonville, FL. Robotic bronch, #EBUS, #cryobiopsy, #stenting + more — live cases & sim labs. Register: https://t.co/TeMuBxghpJ
#Bronchoscopy #SAB @MayoMedEd

[The Thoracic Surgery Foundation (TSF) @ThoracicSurgFnd]

🌍 Applications are open for the TSF/FFF International Travelling Fellowship!
Gain global experience, learn from leading experts, and build lifelong professional connections in cardiothoracic surgery.
Apply by September 15, 2026: https://t.co/zc4ivIdGRh

[The Annals of Thoracic Surgery @annalsthorsurg]

Our September 2026 issue is now available online👇

https://t.co/DToDTXZqJJ

[Jose Fernando Moura, PhD @FernandoOnco]

WCLC 2026: os 40 estudos de câncer de pulmão que estou de olho 👀 @GBOT_Alerta @IASLC #wclc26

[Hidehito HORINOUCHI @HHorinouchi]

🔥KEYNOTE-671: 5-year outcomes of perioperative pembrolizumab for early-stage NSCLC
🆙 @Annals_Oncology @myESMO
🎯5-y EFS 49.9 vs 26.5% (HR 0.58, 95% CI, 0.48‒0.69)
🎯5-y OS 64.6 vs 53.6% (HR 0.74, 95% CI, 0.59‒0.92)
🎙 @HwakeleeMD
#LCSM @OncoAlert @Larvol
https://t.co/eaZb5WnfDz

[AATS @AATSHQ]

#TechniquesThursday: Early clinical experience with a novel single-port robotic system for mediastinal tumor resection: A feasibility and safety assessment. Read about the evolving technology in #JTCVS Techniques: https://t.co/kH3xixPpj7

[IASLC @IASLC]

Explore what’s next in thoracic oncology November 12–14 in São Paulo, #Brazil. 🌎

Connect with experts from across #LatinAmerica and around the world while exploring the latest in #lungcancer screening, precision medicine, surgery, #radiation, #targetedtherapies, #immunotherapy, and more.

📆 November 12–14
⏰ Save with discounted registration through Aug. 24.

Register: https://t.co/6ZvswIKXB7

#ITMIG26 #ThoracicOncology #PrecisionMedicine #CancerResearch #Oncology

[Nicholas Kolaitis, MD MAS @LungTxptMD]

@ross_prager You should try it in your icu sometime instead of keeping patients who can’t be extubated in bed. Lots of reasons to mobilize the critically ill patient who needs life support. You can see a video of us walking a patient while trached and on ecmo here. https://t.co/14DaZTVi0M

[ESTS @thoracic]

The ESTS Database - the largest trans-national database in thoracic surgery - has been upgraded. 🔬 Secure, GDPR-compliant & powered by REDCap. Register your unit today 👉 https://t.co/qEJAMwa4ff #ThoracicSurgery #ESTSDatabase #ClinicalResearch

[AATS @AATSHQ]

The Ninth Edition TNM Stage Classification of Lung Cancer: What’s New? Log in to read the invited expert opinion from James Huang @MSKCancerCenter and Frank Detterbeck @YaleCTSurgery in Seminars in Thoracic and Cardiovascular Surgery: https://t.co/BzKxjTQS1N

[AATS @AATSHQ]

Open access in #JTCVS: Safety and efficacy of a dedicated pulmonary thromboendarterectomy fellowship. Read the short- and long-term outcomes from the Royal Papworth experience at a high-volume center: https://t.co/HRtgAcVluU

[U. Clin Inv cardiopulmonar y Metabólica @clic_cardioiner]

Les compartimos la nueva revisión de @erspublications sobre la hipertensión pulmonar asociada a enfermedad pulmonar intersticial (ILD-PH):
Pulmonary hypertension associated with interstitial lung disease: a state-of-the-art review
DOI: 10.1183/13993003.02651-2025
@EuroRespSoc

[jpedrokessner @KessnerJp]

Pulmonary Hypertension associated with Interstitial Lung Disease.
@ERSpublications a state-of-the-art review.
🫁😨❤️‍🩹🫀✍️🏻📚
@EuroRespSoc @ALATorax @SeparRespira @NeumoMadrid @Neumosur @socapnet @pneumosbpt @neumoparatodos @HUReinaSofia
https://t.co/LiIkKlG9RD

[Respiratory Therapy Zone @RespiratoryZone]

Use this lung nodule size chart to learn what different measurements may mean and when follow-up testing or closer monitoring may be recommended. https://t.co/hIzwHrKXVu

[AATS @AATSHQ]

Surgeons at @Penn say en-bloc lung transplantation is rare but useful. Read why they say EBLT serves as an important option for certain patients with central airway pathology in #JTCVS Techniques: https://t.co/I6pDFYFBBW

[The Pulmonary Vascular Research Institute @PVRI]

Next up in our 'Cutting Edge Innovation in Clinical & Experimental PH' series...

Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 - 17:30 BST

We'll be hearing talks on :
▪️Shared and Distinct Genomics of CTEPH and Pulmonary Embolism - James Liley, Durham University
▪️Balloon Angioplasty for CTEPH: Indications, Results, and Treatment Considerations - Irene Lang, Medical University of Vienna
▪️Distal Pulmonary Endarterectomy: When, How, Why? - Victor Pretorius, Emory University
▪️Lung transplantation for CTEPH - Brett Cronin, University of California, San Diego

➡️ Register here: https://t.co/0BRlBdMmnW

[The ISHLT @ISHLT]

📽️🔥 Learn more about the latest in #PVD, #PAH, and #CTEPH science that was discussed at #ISHLT2026 in Toronto. 🫁⤵️

[EACTS @EACTS]

New MMCTS tutorial! 📣

🎥 Watch here: https://t.co/DQFNSgVIv6

@drsabita, @Docvk2, @niyogidevayani, @virendrakt05